Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
BYON - Beyond Inc - Stock Price Chart
TickerBYON [NYSE, RUT]
CompanyBeyond Inc
CountryUSA
IndustryInternet Retail
Market Cap225.27MEPS (ttm)-5.54
P/E-EPS this Y47.74%
Forward P/E-EPS next Y42.75%
PEG-EPS past 5Y-9.95%
P/S0.16EPS next 5Y50.09%
P/B1.33EPS Q/Q53.32%
Dividend-Sales Q/Q-21.15%
Insider Own1.74%Inst Own57.93%
Insider Trans34.84%Inst Trans14.24%
Short Float17.01%EarningsApr 28/a
Analyst Recom2.56Target Price10.50
Avg Volume3.51M52W Range3.54 - 24.88
Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Midvale, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Putnam Leah RChief Accounting OfficerApr 12 '25Option Exercise0.001,50002,625Apr 15 04:12 PM
Thomas Alexander WilliamChief Operating OfficerApr 12 '25Option Exercise0.001,77808,559Apr 15 04:09 PM
LEMONIS MARCUSEXECUTIVE CHAIRMAN OF BOARDMar 13 '25Buy5.0319,19396,541456,151Mar 13 04:00 PM
Nielsen David J.PRESIDENTJan 23 '25Option Exercise0.0020,964283,901Jan 23 08:16 PM
Nielsen David J.PRESIDENTJan 21 '25Option Exercise0.006,667165,218Jan 23 08:16 PM
TCRX - Tscan Therapeutics Inc - Stock Price Chart
TickerTCRX [NASD, RUT]
CompanyTscan Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap81.49MEPS (ttm)-1.06
P/E-EPS this Y-14.36%
Forward P/E-EPS next Y4.01%
PEG-EPS past 5Y-14.41%
P/S28.90EPS next 5Y7.58%
P/B0.34EPS Q/Q27.70%
Dividend-Sales Q/Q-90.78%
Insider Own23.53%Inst Own69.40%
Insider Trans1.01%Inst Trans-2.70%
Short Float4.68%EarningsMar 05/b
Analyst Recom1.12Target Price9.71
Avg Volume417.01K52W Range1.02 - 9.69
TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lynx1 Capital Management LP10% OwnerDec 13 '24Buy2.90100,000290,1405,357,347Dec 16 04:26 PM
Lynx1 Capital Management LP10% OwnerDec 12 '24Buy3.0131,80095,6295,257,347Dec 16 04:26 PM
Lynx1 Capital Management LP10% OwnerNov 15 '24Buy4.349474,1145,225,547Nov 19 04:26 PM
Klencke BarbaraDirectorSep 23 '24Buy5.295,00026,45045,000Sep 24 05:26 PM
Klencke BarbaraDirectorAug 23 '24Buy5.695,00028,45035,000Aug 27 06:57 PM
BTCS - BTCS Inc - Stock Price Chart
TickerBTCS [NASD]
CompanyBTCS Inc
CountryUSA
IndustryCapital Markets
Market Cap33.30MEPS (ttm)-0.24
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y40.99%
P/S8.30EPS next 5Y-
P/B0.99EPS Q/Q-83.16%
Dividend-Sales Q/Q611.93%
Insider Own38.51%Inst Own4.36%
Insider Trans-2.78%Inst Trans14.85%
Short Float3.75%EarningsMar 20/b
Analyst Recom1.00Target Price5.00
Avg Volume499.69K52W Range0.95 - 5.41
BTCS, Inc. engages in the digital currency ecosystem and blockchain technologies. It manages an online marketplace where consumers can purchase merchandise using digital currencies such as bitcoin. The company was founded by Timothy Sidie and Michal Handerhan on April 15, 2008 and is headquartered in Silver Spring, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Allen Charles WCEOApr 07 '25Sale1.3785,000116,7484,293,622Apr 09 06:26 PM
Allen Charles WCEOApr 09 '25Sale1.4465,00093,5874,178,622Apr 09 06:26 PM
Allen Charles WCEOApr 08 '25Sale1.4450,00072,2054,243,622Apr 09 06:26 PM
Paranjape ManishFormer Chief Technology OfficeApr 07 '25Proposed Sale1.46158,047230,749Apr 07 08:47 AM
Handerhan MichalCOOMar 05 '25Proposed Sale7.53750,0005,650,000Feb 27 02:58 PM
SION - Sionna Therapeutics Inc - Stock Price Chart
TickerSION [NASD]
CompanySionna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap488.46MEPS (ttm)-
P/E-EPS this Y86.26%
Forward P/E-EPS next Y-8.19%
PEG-EPS past 5Y-
P/S-EPS next 5Y45.72%
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own38.70%Inst Own30.36%
Insider Trans25.50%Inst Trans29.35%
Short Float8.43%EarningsMar 20/b
Analyst Recom1.00Target Price38.50
Avg Volume253.18K52W Range7.26 - 25.19
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TPG GP A, LLC10% OwnerFeb 10 '25Buy18.001,125,00020,250,0006,684,962Feb 12 05:21 PM
RA CAPITAL MANAGEMENT, L.P.DirectorFeb 10 '25Buy18.001,125,00020,250,0006,923,365Feb 10 05:04 PM
ORBIMED ADVISORS LLCDirectorFeb 10 '25Buy18.00550,0009,900,0003,704,959Feb 10 04:28 PM
Thompson Peter A.DirectorFeb 10 '25Buy18.00550,0009,900,0003,704,959Feb 10 04:05 PM
Booth BruceDirectorFeb 10 '25Buy18.0060,0001,080,000807,727Feb 10 04:05 PM
ZONE - CleanCore Solutions Inc - Stock Price Chart
TickerZONE [AMEX]
CompanyCleanCore Solutions Inc
CountryUSA
IndustryPollution & Treatment Controls
Market Cap9.96MEPS (ttm)-0.48
P/E-EPS this Y77.50%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S6.23EPS next 5Y-
P/B4.41EPS Q/Q-23.00%
Dividend-Sales Q/Q0.00%
Insider Own75.20%Inst Own2.10%
Insider Trans0.33%Inst Trans0.16%
Short Float3.72%EarningsNov 13/b
Analyst Recom-Target Price-
Avg Volume167.06K52W Range0.81 - 4.24
Apr-17-25 08:30AM CleanCore Solutions, Inc. (ZONE) Completes Acquisition of Sanzonate Europe, Enhancing Leadership Position within the Industry (GlobeNewswire) +10.70%
Feb-25-25 09:00AM CleanCore Solutions, Inc. (ZONE) Signs Definitive Agreement to Acquire Sanzonate Europe, the Largest Aqueous Ozone Product Distributor in Europe, Strengthening Financial Performance and Unlocking a Multi-Million Dollar Sales Pipeline (GlobeNewswire) +7.48%
08:30AM EXCLUSIVE: CleanCore Seals $2.48 Million Sanzonate Deal With $1.25 Million Earnout, Unlocks $20 Million Sales Pipeline in Europe (Benzinga)
Feb-14-25 08:30AM CleanCore Solutions, Inc. (ZONE) Reports Second Quarter FY 2025 Financial Results and Provides Business Update (GlobeNewswire) -6.51%
Jan-29-25 08:30AM CleanCore Solutions, Inc. (ZONE) Launches Product Rollout at Major International New York Airport (GlobeNewswire)
Jan-06-25 08:30AM CleanCore Solutions, Inc. (ZONE) Appoints Travis Buchanan as President (GlobeNewswire)
Dec-18-24 08:30AM CleanCore Solutions, Inc. (ZONE) Applauds EPA's Recent Ban of Two Cancer-Causing Chemicals (GlobeNewswire) -17.61%
Nov-18-24 08:30AM CleanCore Solutions, Inc. (ZONE) Launches Pilot Program with International Hotel Chain (GlobeNewswire) -18.96%
Nov-13-24 08:30AM CleanCore Solutions, Inc. (ZONE) Reports First Quarter FY 2025 Financial Results and Provides Business Update (GlobeNewswire) +13.33%
Oct-24-24 08:30AM CleanCore Solutions, Inc. (ZONE) Expands Early Education Vertical with Montessori Schools (GlobeNewswire)
CleanCore Solutions, Inc. engages in development and sale of cleaning products that produces pure aqueous ozone for professional, industrial, and home use. The company's product includes fill station, power caddy, and power mini caddy, ice treatment machine, commercial laundry, residential laundry, industrial cleaning, and sanitizing and disinfectant tablets. It offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. CleanCore Solutions, Inc. was formerly known as CC Acquisition Corp. and changed its name to CleanCore Solutions, Inc. in November 2022. CleanCore Solutions, Inc. was incorporated in 2022 and is headquartered in Omaha, Nebraska.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adams ClaytonChief Executive OfficerFeb 25 '25Buy0.982,0001,970493,000Mar 10 04:12 PM
Enholm David JamesChief Financial OfficerMar 07 '25Buy1.148,5509,7818,550Mar 07 04:22 PM
Adams ClaytonChief Executive OfficerNov 15 '24Buy2.1210,00021,198491,000Nov 19 04:05 PM
Basestones Inc10% OwnerOct 30 '24Proposed Sale1.40127,294178,212Oct 31 05:12 PM
Adams ClaytonChief Executive OfficerJun 28 '24Buy2.375,00011,850481,000Jul 02 04:10 PM
CRML - Critical Metals Corp - Stock Price Chart
TickerCRML [NASD, RUT]
CompanyCritical Metals Corp
CountryUSA
IndustryOther Industrial Metals & Mining
Market Cap222.58MEPS (ttm)-1.96
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-1061.66%
P/S-EPS next 5Y-
P/B3.03EPS Q/Q-493.10%
Dividend-Sales Q/Q-
Insider Own81.18%Inst Own10.75%
Insider Trans0.00%Inst Trans4.32%
Short Float6.72%Earnings-
Analyst Recom-Target Price-
Avg Volume1.06M52W Range1.23 - 12.49
Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.
ELUT - Elutia Inc - Stock Price Chart
TickerELUT [NASD]
CompanyElutia Inc
CountryUSA
IndustryMedical Devices
Market Cap94.81MEPS (ttm)-2.48
P/E-EPS this Y58.60%
Forward P/E-EPS next Y38.31%
PEG-EPS past 5Y-10.72%
P/S3.89EPS next 5Y-
P/B-EPS Q/Q60.62%
Dividend-Sales Q/Q-6.93%
Insider Own38.70%Inst Own29.98%
Insider Trans5.61%Inst Trans35.81%
Short Float0.26%EarningsMar 06/a
Analyst Recom1.00Target Price9.00
Avg Volume43.33K52W Range1.87 - 5.24
Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. It operates through the following segments: Device Protection, Women's Health, and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women's Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Cardiovascular segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Silver Spring, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HighCape Capital, L.P.DirectorFeb 03 '25Buy2.50420,0001,050,0009,520,232Mar 13 04:30 PM
HighCape Capital, L.P.DirectorFeb 03 '25Buy2.50420,0001,050,0009,520,232Mar 13 04:28 PM
Ferguson MatthewCHIEF FINANCIAL OFFICERJul 31 '24Option Exercise1.43105,080150,002257,823Jul 31 05:00 PM
HAIN - Hain Celestial Group Inc - Stock Price Chart
TickerHAIN [NASD, RUT]
CompanyHain Celestial Group Inc
CountryUSA
IndustryPackaged Foods
Market Cap268.03MEPS (ttm)-1.94
P/E-EPS this Y4.85%
Forward P/E6.21EPS next Y38.27%
PEG-EPS past 5Y9.39%
P/S0.16EPS next 5Y19.48%
P/B0.33EPS Q/Q-665.49%
Dividend-Sales Q/Q-9.38%
Insider Own0.98%Inst Own114.07%
Insider Trans0.65%Inst Trans3.01%
Short Float6.86%EarningsMay 07/b
Analyst Recom2.43Target Price6.29
Avg Volume2.29M52W Range2.68 - 9.43
The Hain Celestial Group, Inc. engages in the production and distribution of organic and natural products. It operates through North America and International geographical segments. The North America segment consists of the United States and Canada. The International segment includes the United Kingdom, Ella's Kitchen UK, and Europe. The company was founded by Irwin David Simon on May 19, 1993 and is headquartered in Hoboken, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Marquardt Chad D.President, North AmericaFeb 20 '25Buy4.043,20012,92823,025Feb 21 08:00 AM
Marquardt Chad D.President, North AmericaNov 11 '24Buy7.462,50018,63819,825Nov 12 08:01 AM
Marquardt Chad D.President, North AmericaSep 10 '24Buy8.29100828100Sep 11 04:03 PM
Davidson Wendy PPresident and CEOSep 09 '24Buy8.30100830100Sep 11 04:01 PM
Marquardt Chad D.President, North AmericaSep 04 '24Buy8.325,30044,09615,300Sep 05 08:28 AM
IMNM - Immunome Inc - Stock Price Chart
TickerIMNM [NASD, RUT]
CompanyImmunome Inc
CountryUSA
IndustryBiotechnology
Market Cap687.78MEPS (ttm)-5.18
P/E-EPS this Y48.00%
Forward P/E-EPS next Y-7.18%
PEG-EPS past 5Y-38.15%
P/S76.08EPS next 5Y21.19%
P/B2.81EPS Q/Q69.67%
Dividend-Sales Q/Q-28.44%
Insider Own13.27%Inst Own61.52%
Insider Trans4.07%Inst Trans8.04%
Short Float14.76%EarningsMar 19/a
Analyst Recom1.00Target Price26.00
Avg Volume1.16M52W Range5.15 - 18.56
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Higgins JackChief Scientific OfficerMar 27 '25Option Exercise1.355,2007,02018,729Mar 28 05:54 PM
BIENAIME JEAN JACQUESDirectorMar 25 '25Buy7.787,80060,68431,415Mar 26 04:05 PM
SIEGALL CLAY BPresident and CEOMar 26 '25Buy7.29137,100999,459806,736Mar 26 04:03 PM
BIENAIME JEAN JACQUESDirectorMar 24 '25Buy8.217,00057,47023,615Mar 25 05:18 PM
Tsai PhilipChief Technology OfficerMar 24 '25Buy8.4212,300103,56633,300Mar 25 05:15 PM
VCIG - VCI Global Ltd - Stock Price Chart
TickerVCIG [NASD]
CompanyVCI Global Ltd
CountryMalaysia
IndustryConsulting Services
Market Cap8.40MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own4.64%Inst Own0.12%
Insider Trans0.00%Inst Trans-
Short Float1.18%Earnings-
Analyst Recom-Target Price-
Avg Volume161.58K52W Range2.30 - 1372.00
VCI Global Ltd. engages in the provision of business consulting services. It operates through the following segments: Business Strategy Consultancy, Technology Consultancy, and Others. The Business Strategy Consultancy segment offers services relating to listing solutions, investors relations, and boardroom strategies. The Technology Consultancy segment specializes in digital development and software solutions. The company was founded in 2013 and is headquartered in Kuala Lumpur, Malaysia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HONG KHAY KUANDirectorFeb 13 '25Proposed Sale1.0030,06530,065Feb 06 04:12 PM
Hong Khay KuanDirectorSep 27 '24Proposed Sale0.12630,36278,165Sep 18 01:28 PM
15678910111213141520